Amitiza (lubiprostone)

Manufacturer:
Misc
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form

    Approved Indication:

    • treatment of irritable bowel syndrome with constipation in women 18 years of age and older
    • treatment of chronic idiopathic constipation in adults
    • treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not required frequent opioid dose escalation

    Conditions:

    • Irritable Bowel Syndrome with Constipation (IBS-C)
    • Chronic Idiopathic Constipation (CIC)
    • Opioid-Induced Constipation (OIC)

    Therapeutic Area:

    • Gastroenterology